Send the following on WhatsApp
Continue to ChatIbrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study - https://avesis.erciyes.edu.tr/publication/details/4c83cbda-dfea-448b-a669-2cff2c1b0708/ibrutinib-combined-with-bendamustine-and-rituximab-compared-with-placebo-bendamustine-and-rituximab-for-previously-treated-chronic-lymphocytic-leukaemia-or-small-lymphocytic-lymphoma-helios-a-randomised-double-blind-phase-3-study